You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
一品紅(300723.SZ):全資子公司獲得羧甲司坦口服溶液註冊證書
格隆匯 06-04 20:03

格隆匯6月4日丨一品紅(300723.SZ)公佈,公司全資子公司廣州市聯瑞製藥有限公司於近日收到國家藥品監督管理局核准簽發的關於羧甲司坦口服溶液的《藥品註冊證書》。

根據核准的説明書,羧甲司坦口服溶液適應症為:用於治療慢性支氣管炎、支氣管哮喘等疾病引起的痰液粘稠、咳痰困難患者。本品為粘液調節劑,主要作用於支氣管腺體的分泌,使低粘度的唾液粘蛋白分泌增加,高粘度的巖藻粘蛋白產生減少,因而使痰液的粘稠性降低而易於咳出。適用於2歲及以上兒童及成人使用。

羧甲司坦口服溶液是國家醫保乙類產品。公司獲批的羧甲司坦口服溶液是以化學藥品3類申報註冊,視同通過一致性評價。根據米內網數據,2024年羧甲司坦口服溶液在中國城市和縣級公立醫院的銷售規模約為6.1097億元人民幣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account